Your browser doesn't support javascript.
loading
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial.
Macedo, Ariane Vieira Scarlatelli; de Barros E Silva, Pedro Gabriel Melo; de Paula, Thiago Ceccatto; Moll-Bernardes, Renata Junqueira; Mendonça Dos Santos, Tiago; Mazza, Lilian; Feldman, Andre; Arruda, Guilherme D Andréa Saba; de Albuquerque, Denílson Campos; de Sousa, Andrea Silvestre; de Souza, Olga Ferreira; Gibson, C Michael; Granger, Christopher B; Alexander, John H; Lopes, Renato D.
Afiliación
  • Macedo AVS; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Hospital São Luiz Jabaquara, São Paulo, Brazil; Programa de Pós-Graduação em Medicina Translacional, Universidade Federal de São Paulo, São Paulo, Brazil; Brazilian Clinical Research Institute, São Paulo, Brazil.
  • de Barros E Silva PGM; Brazilian Clinical Research Institute, São Paulo, Brazil; Centro Universitário São Camilo, São Paulo, Brazil.
  • de Paula TC; Hospital São Luiz Jabaquara, São Paulo, Brazil; Brazilian Clinical Research Institute, São Paulo, Brazil.
  • Moll-Bernardes RJ; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
  • Mendonça Dos Santos T; Brazilian Clinical Research Institute, São Paulo, Brazil; Insper Institute of Education and Research, São Paulo, Brazil.
  • Mazza L; Brazilian Clinical Research Institute, São Paulo, Brazil.
  • Feldman A; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Hospital São Luiz Anália Franco, São Paulo, Brazil.
  • Arruda GDAS; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Hospital São Luiz São Caetano, São Caetano do Sul, Brazil.
  • de Albuquerque DC; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
  • de Sousa AS; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
  • de Souza OF; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Rede D'Or São Luiz (RDSL), São Paulo, Brazil; Hospital Copa D'Or, Rio de Janeiro, Brazil.
  • Gibson CM; Harvard Medical School, Boston, MA, USA.
  • Granger CB; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
  • Alexander JH; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
  • Lopes RD; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Programa de Pós-Graduação em Medicina Translacional, Universidade Federal de São Paulo, São Paulo, Brazil; Brazilian Clinical Research Institute, São Paulo, Brazil; Rede D'Or São Luiz (RDSL), São Paulo, Brazil; Duke Clinical R
Am Heart J ; 249: 86-97, 2022 07.
Article en En | MEDLINE | ID: mdl-35405099
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Hipertensión Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Am Heart J Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Hipertensión Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Am Heart J Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos